New Identity-Based therapy aims to beat standard CBT for young adults

NCT ID NCT06384196

Recruiting now Symptom relief Sponsor: University of Barcelona Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jul 09, 2026 · Updated 3 times

Summary

This study tests a new type of talk therapy called Identity-Based Transdiagnostic Therapy (IBTT) for young adults with anxiety or depression. It compares IBTT to a well-known therapy called the Unified Protocol (CBT-based). The goal is to see if IBTT is more engaging and effective at reducing symptoms. The trial will involve 138 participants and uses online tools to explore personal identity.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Identity-Based Transdiagnostic Therapy (IBTT) - a type of talk therapy
What this could lead to: If it works, this could offer a more engaging and effective therapy option for young adults struggling with anxiety or depression.
What could go wrong: This is a relatively small, early-stage trial (138 participants) comparing a new therapy to an established one. The new therapy may not prove more effective, and results may not apply to everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANXIETY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

anxiety anxiety disorder Depression depressive disorder Patient Satisfaction Personal Satisfaction Psychological Well-Being

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANXIETY DEPRESSION

Contacts and locations

Locations

Associació Centre Higiene Mental Nou Barris
RECRUITING

Barcelona, 08042, Spain
Badalona Serveis Assistencials
RECRUITING

Badalona, 08911, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.